Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.39 is 28% below its 5-year average of -1.09, around the middle of its 5-year range (-1.95–-0.09).
19.53% below its 12-month average of -1.16.
Reported quarterly EPS; no daily interpolation. Q3 FY2026 (2026-06-30): -0.39.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.39
EARNINGS PER SHARE (EPS) AVG TTM
-1.16
EARNINGS PER SHARE (EPS) AVG 3Y
-1.40
EARNINGS PER SHARE (EPS) AVG 5Y
-1.09
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-19.53%
CURRENT VS 3Y AVG
+0.61%
CURRENT VS 5Y AVG
-27.73%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Optimi Health Corp.
Market Cap
$13.51M
Earnings Per Share (EPS)
-1.39
TTM Avg
-1.16
3Y Avg
-1.40
5Y Avg
-1.09
Market Cap
$13.60M
Earnings Per Share (EPS)
-2.11
TTM Avg
-3.38
3Y Avg
-4.90
5Y Avg
-6.31
Market Cap
$13.14M
Earnings Per Share (EPS)
-1.87
TTM Avg
-10.75
3Y Avg
-23.11
5Y Avg
-21.98
Market Cap
$13.92M
Earnings Per Share (EPS)
-5.41
TTM Avg
-10.52
3Y Avg
-27.78
5Y Avg
-33.88
Market Cap
$13.93M
Earnings Per Share (EPS)
-29.90
TTM Avg
-175.25
3Y Avg
-40254.86
5Y Avg
-180507.78
Market Cap
$12.95M
Earnings Per Share (EPS)
-11.33
TTM Avg
-17.89
3Y Avg
-30.77
5Y Avg
-41.73
Market Cap
$12.94M
Earnings Per Share (EPS)
-4.56
TTM Avg
-22.43
3Y Avg
-71.26
5Y Avg
-107.32
Market Cap
$14.11M
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$14.14M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.17
3Y Avg
-1.46
5Y Avg
-1.36
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Optimi Health Corp. (OPTH) | $13.51M | -1.39 | -1.16 | -1.40 | -1.09 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.60M | -2.11 | -3.38 | -4.90 | -6.31 |
| IN8bio, Inc. (INAB)vs › | $13.14M | -1.87 | -10.75 | -23.11 | -21.98 |
| Sintx Technologies, Inc. (SINT)vs › | $13.92M | -5.41 | -10.52 | -27.78 | -33.88 |
| Vyome Holdings, Inc. (HIND)vs › | $13.93M | -29.90 | -175.25 | -40254.86 | -180507.78 |
| Passage Bio, Inc. (PASG)vs › | $12.95M | -11.33 | -17.89 | -30.77 | -41.73 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.94M | -4.56 | -22.43 | -71.26 | -107.32 |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.11M | N/A | N/A | N/A | N/A |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.14M | N/A | -1.17 | -1.46 | -1.36 |
| Cytosorbents Corporation (CTSO)vs › | $12.73M | -5.75 | -5.10 | -9.55 | -8.93 |
Trailing EPS (TTM)
$-1.39
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-09-30 | -0.83 |
| 2024-09-30 | -1.49 |
| 2023-09-30 | -1.32 |
| 2022-09-30 | -1.95 |
| 2021-09-30 | -0.09 |
| 2020-09-30 | -0.84 |
